Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
All news
(page 62)
19 February 2026
BENEO Names Dr Uwe Boltersdorf as COO
Dr Uwe Boltersdorf, with 20+ years in management, becomes COO, overseeing operations, production, and sustainability, while retaining his role at CropEnergies AG.
19 February 2026
INEOS Secures €300M French Grant to Decarbonise Lavera Site
The investment cuts CO2 by 331,000 tonnes annually, secures jobs, boosts competitiveness, and supports France's industrial and climate goals through electrification and carbon capture.
19 February 2026
AGC Biologics Gains Anvisa GMP Certification for Seattle Facility
The Seattle site can now supply biopharmaceuticals to Brazil, enhancing AGC's global supply capabilities and expanding regulatory approvals to over 11 countries.
19 February 2026
ORLEN Group Reports Strong 2025 with Record Investments
In Q4 2025, LIFO-based EBITDA hit PLN 12.2B. Annual EBITDA reached PLN 41.9B, net profit PLN 11.2B. Investments of PLN 32.6B focused on energy security and low-carbon sources.
19 February 2026
Asahi Kasei Pharma Partners with MAIA for U.S. Teribone™ Development
MAIA will develop and commercialize Teribone™ in the U.S. to address the growing osteoporosis patient population, expanding access to proven bone-forming therapy.
19 February 2026
Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition
Thin-film Hall elements, launched in 1983, revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
News type
Project Updates and Milestones
New Projects and Expansions
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Operational Changes and Investments
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
18 February 2026
AFC Energy permitted to export and sell low‑carbon hydrogen from Dunsfold pilot plant
Environment Agency approved export/sale of low‑carbon ISO 14687 D hydrogen from Dunsfold pilot (up to 300kg/day); JV with ICL advancing Hy‑5 rollout and permitting for larger sites.
18 February 2026
Asahi Kasei Pharma and Alchemedicine: AK1960 enters Phase I for refractory diseases
AK1960, a novel ETA receptor antagonist with a new core structure, shows high ETA selectivity and kidney-disease efficacy in animals and has advanced to Phase I for refractory diseases.
18 February 2026
AFC Energy Gains Approval to Export and Sell Low Carbon Hydrogen from Ammonia Cracking Plant
The UK Environment Agency's permit revision allows hydrogen production training at Dunsfold and supports future deployments with Industrial Chemicals Group Ltd.
18 February 2026
Asahi Kasei Pharma Advances AK1960 to Phase I for Refractory Diseases
AK1960, an ETA receptor antagonist, enters Phase I trials for refractory diseases, leveraging Alchemedicine's HiSAP™ platform and partnerships with Calliditas and Veloxis.
18 February 2026
Toray's Ehime and Nagoya Plants Achieve ISCC PLUS Certification for Engineering Plastics
Two plants gain ISCC PLUS certification, enabling use of biomass and recycled materials in PBT and LCP resins, supporting carbon footprint reduction.
18 February 2026
Iberdrola Named Most Sustainable Electricity Company for Seventh Year
Ranked 17th in Clean200, Iberdrola excels in sustainability, energy security, and competitiveness, outperforming fossil fuel firms and earning top ESG ratings.
18 February 2026
Johnson & Johnson Invests $1 Billion in Pennsylvania Cell Therapy Facility
The new facility in Montgomery County will boost U.S. manufacturing capacity for cancer, immune-mediated, and neurological disease treatments.
18 February 2026
Johnson & Johnson's RYBREVANT FASPRO™ Gains FDA Breakthrough Status for Advanced Head and Neck Cancer
FDA grants Breakthrough Therapy Designation to RYBREVANT FASPRO™ for HPV-unrelated head and neck cancer after platinum-based chemotherapy and PD-1/PD-L1 inhibitor.
18 February 2026
PureCycle and TOPPAN Partner for Sustainable Recycled Packaging Solutions
They developed a snack bar wrapper with 30% recycled content, targeting thermoforming applications to meet regulatory demands without compromising safety or performance.
18 February 2026
Merck and Mayo Clinic Collaborate on AI-Driven Drug Discovery
The collaboration combines clinical data and AI to enhance drug discovery, focusing on gastroenterology, dermatology, and neurology for tailored therapies.
18 February 2026
Baltic Power Completes Foundation Installation for Offshore Wind Farm
All 78 monopile foundations are installed at Poland's first offshore wind farm, with electricity set to be supplied by year-end. Construction completion is expected in late 2026.
18 February 2026
Lilly's Taltz and Zepbound Show Superior Results in Psoriasis and Obesity Trial
Taltz and Zepbound together improved skin clearance and weight loss in psoriasis patients with obesity, outperforming Taltz alone in a Phase 3b trial.
18 February 2026
VolagHy Releases EIA Program for Kuopio Site
The EIA program for the Kuopio site outlines environmental, social, and land-use assessments, moving the project into the formal evaluation phase with stakeholder engagement.
18 February 2026
Asahi Kasei Pharma Begins Phase I Study of AK1960
AK1960, a selective endothelin A receptor antagonist, shows promise for treating refractory kidney diseases, aligning with R&D strategies for unmet medical needs.
18 February 2026
NEXTCHEM Secures Licensing Deal in China for NX CONSER™ Technologies
The technologies will enable efficient co-production of BDO and DMS, supporting biopolymer production with improved cost, energy efficiency, and sustainability.
17 February 2026
Vattenfall Divests French Sales Business to Alterna énergie
Vattenfall transfers its French electricity and gas sales business, ensuring seamless service continuity. Alterna énergie will integrate all employees and maintain existing contracts.
17 February 2026
Vattenfall Divests French Sales Business to Alterna énergie
The transaction includes 15,000 business customers, 3,000 large accounts, and 175,000 residential contracts. All employees will transfer, ensuring seamless service continuity.
17 February 2026
Mitsubishi Chemical Transfers Synthetic Resin Emulsion Business
Mitsubishi Chemical transfers its synthetic and acrylic emulsion businesses to Konishi, aiming for sustainable growth and competitive advantage. Transfer completes December 1, 2026.
17 February 2026
Perstorp Expands Liquid Cooling Solutions for Data Centers
Perstorp introduces Synplate™ and expands Synmerse™ for efficient, safe liquid cooling in data centers, enhancing performance and sustainability.
17 February 2026
Huntsman Q4 2025 Earnings Report
Q4 2025 net loss of $96M, adjusted net loss of $63M. Adjusted EBITDA at $35M. Free cash flow from operations at $20M, down from $108M last year.
17 February 2026
Novo Nordisk: EU Approves Higher Wegovy® Dose for Obesity, 21% Average Weight Loss
The EU approved a 7.2 mg Wegovy® dose for obesity. In studies, participants lost 21% body weight on average. Common side effects: nausea, diarrhea, vomiting, and dysaesthesia.
17 February 2026
Genmab Releases 2025 Annual Report
The report highlights 2025 achievements, financials, and 2026 outlook, including revenue growth, strategic acquisitions, and regulatory approvals.
17 February 2026
FDA Approves Johnson & Johnson's Monthly EGFR Therapy RYBREVANT FASPRO
FDA approves monthly dosing for RYBREVANT FASPRO, maintaining efficacy and reducing administration time and reactions compared to bi-weekly and IV schedules for EGFR-mutated NSCLC treatment.
17 February 2026
Fluor 2025 Financial Results Summary
2025 saw $754M in share repurchases, $12B in new awards, and a $25.5B backlog. Revenue hit $15.5B with a $51M net loss. $1.35B received from NuScale share sales in Q1 2026.
← Previous
Next →
